IASO Biotherapeutics
About:
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.
Website: http://www.iasobio.com/
Top Investors: Hillhouse Investment, Innovent Biologics, CDH Investments, Co-Stone Venture Capital, GL Ventures LLC
Description:
IASO Biotherapeutics (IASO BIO) is a Nanjing-based biopharmaceutical company focused on the discovery, development and commercialization of cell therapies in the field of oncology.
Total Funding Amount:
$242M
Estimated Revenue Range:
$50M to $100M
Headquarters Location:
Nanjing, Jiangsu, China
Founded Date:
2017-01-01
Contact Email:
lu.song(AT)iasobio.com
Founders:
Xuefei Huang
Number of Employees:
251-500
Last Funding Date:
2024-07-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai